H. Graffner

3.7k total citations
74 papers, 2.9k citations indexed

About

H. Graffner is a scholar working on Surgery, Gastroenterology and Oncology. According to data from OpenAlex, H. Graffner has authored 74 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 24 papers in Gastroenterology and 18 papers in Oncology. Recurrent topics in H. Graffner's work include Helicobacter pylori-related gastroenterology studies (25 papers), Gastroesophageal reflux and treatments (17 papers) and Gastrointestinal motility and disorders (13 papers). H. Graffner is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (25 papers), Gastroesophageal reflux and treatments (17 papers) and Gastrointestinal motility and disorders (13 papers). H. Graffner collaborates with scholars based in Sweden, United States and United Kingdom. H. Graffner's co-authors include J Oscarson, Michael Camilleri, Leif Rikner, Björn Ohlsson, K.‐G. Tranberg, Henrik Ekberg, Jeffrey W. Milsom, M. Ekelund, R. Håkanson and Gert Lindell and has published in prestigious journals such as Gastroenterology, Annals of Surgery and American Journal of Obstetrics and Gynecology.

In The Last Decade

H. Graffner

73 papers receiving 2.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
H. Graffner 1.8k 953 854 457 339 74 2.9k
G Labò 1.4k 0.8× 657 0.7× 319 0.4× 608 1.3× 353 1.0× 102 2.5k
Phillip P. Toskes 3.4k 1.9× 934 1.0× 1.6k 1.9× 578 1.3× 466 1.4× 117 4.9k
Timothy T. Nostrant 1.5k 0.9× 710 0.7× 763 0.9× 726 1.6× 172 0.5× 60 2.7k
L. Barbara 953 0.5× 369 0.4× 568 0.7× 863 1.9× 257 0.8× 106 2.5k
W. Sircus 1.5k 0.9× 697 0.7× 322 0.4× 1.1k 2.4× 765 2.3× 114 3.2k
Paul Kerlin 1.9k 1.1× 862 0.9× 188 0.2× 464 1.0× 224 0.7× 80 3.4k
W. O. Kirwan 1.5k 0.9× 310 0.3× 681 0.8× 342 0.7× 340 1.0× 68 2.6k
Lawrence DenBesten 2.3k 1.3× 598 0.6× 905 1.1× 388 0.8× 90 0.3× 91 3.7k
R. Stockbrügger 1.5k 0.9× 834 0.9× 319 0.4× 1.1k 2.5× 1.2k 3.5× 101 3.6k
Bjarni Þjóðleifsson 1.1k 0.6× 757 0.8× 144 0.2× 467 1.0× 412 1.2× 77 2.4k

Countries citing papers authored by H. Graffner

Since Specialization
Citations

This map shows the geographic impact of H. Graffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Graffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Graffner more than expected).

Fields of papers citing papers by H. Graffner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Graffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Graffner. The network helps show where H. Graffner may publish in the future.

Co-authorship network of co-authors of H. Graffner

This figure shows the co-authorship network connecting the top 25 collaborators of H. Graffner. A scholar is included among the top collaborators of H. Graffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Graffner. H. Graffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rudling, Mats, Michael Camilleri, H. Graffner, Jens J. Holst, & Leif Rikner. (2015). Specific inhibition of bile acid transport alters plasma lipids and GLP-1. BMC Cardiovascular Disorders. 15(1). 75–75. 45 indexed citations
3.
Baghdasaryan, Anna, Claudia Fuchs, Christoph H. Österreicher, et al.. (2015). Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. Journal of Hepatology. 64(3). 674–681. 143 indexed citations
4.
Wong, Banny S., Michael Camilleri, Sanna McKinzie, et al.. (2011). Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation. The American Journal of Gastroenterology. 106(12). 2154–2164. 114 indexed citations
5.
Schoon, Erik J., S. Bollani, Peter R. Mills, et al.. (2005). Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn’s disease. Clinical Gastroenterology and Hepatology. 3(2). 113–121. 105 indexed citations
6.
Ronkainen, Jukka, Pertti Aro, Tom Storskrubb, et al.. (2005). High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scandinavian Journal of Gastroenterology. 40(3). 275–285. 354 indexed citations
7.
Ruigómez, Ana, et al.. (2004). Natural history of gastro‐oesophageal reflux disease diagnosed in general practice. Alimentary Pharmacology & Therapeutics. 20(7). 751–760. 164 indexed citations
8.
Hart, AL, et al.. (2002). Review article: The role of the gut flora in health and disease, and its modification as therapy. Alimentary Pharmacology & Therapeutics. 16(8). 11 indexed citations
9.
Hart, A, Andrew J. Stagg, H. Graffner, et al.. (2002). The role of the gut flora in health and disease, and its modification as therapy. Alimentary Pharmacology & Therapeutics. 16(8). 1383–1393. 71 indexed citations
10.
Stockbrügger, R.W., E Schoon, S. Bollani, et al.. (2002). Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Alimentary Pharmacology & Therapeutics. 16(8). 1519–1527. 76 indexed citations
11.
Hellberg, Anders, Claes Rudberg, E Kullman, et al.. (1999). Prospective randomized multicentre study of laparoscopic versus open appendicectomy. British journal of surgery. 86(1). 48–53. 139 indexed citations
12.
Lindell, Gert, et al.. (1997). Acute Effects of High-Dose Intragastric Nicotine on Mucosal Defense Mechanisms An Analysis of Nicotine, Prostaglandin E2, Phospholipase A2, and Phospholipids. Digestive Diseases and Sciences. 42(3). 640–644. 10 indexed citations
13.
Lindell, Gert, E. Lunell, & H. Graffner. (1996). Transdermally administered nicotine accumulates in gastric juice. European Journal of Clinical Pharmacology. 51(3-4). 315–318. 22 indexed citations
14.
Wenner, Jörgen, H. Graffner, & Gert Lindell. (1995). A financial analysis of laparoscopic and open cholecystectomy. Surgical Endoscopy. 9(6). 702–705. 15 indexed citations
15.
Singh, G. Dave, H. Graffner, Jeffrey W. Milsom, & Irshad H. Chaudry. (1993). Tauromustine is more effective than conventional chemotherapy in the treatment of colonic tumors. Diseases of the Colon & Rectum. 36(4). 394–399. 2 indexed citations
16.
17.
Graffner, H., G. Dave Singh, Irshad H. Chaudry, & Jeffrey W. Milsom. (1992). Omeprazole-induced hypergastrinemia does not influence growth of colon carcinoma. Digestive Diseases and Sciences. 37(4). 485–489. 26 indexed citations
18.
Lindell, Gert, et al.. (1991). <i>Helicobacter pylori, </i>Smoking and Gastroduodenitis. Digestion. 49(4). 192–197. 7 indexed citations
19.
Graffner, H., M. Ekelund, & R. Håkanson. (1991). Anaesthetic Agents Suppress Basal and Stimulated Gastric Acid Secretion.: Are Intramural Neurons Involved?. Scandinavian Journal of Gastroenterology. 26(11). 1200–1204. 5 indexed citations
20.
Graffner, H., M. Ekelund, Rolf Håkanson, et al.. (1984). Effects of Upper Abdominal Sympathectomy on Gastric Acid, Serum Gastrin, and Catecholamines in the Rat Gut. Scandinavian Journal of Gastroenterology. 19(6). 711–716. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Labò Breakdown of academic impact, for papers by Phillip P. Toskes Breakdown of academic impact, for papers by Timothy T. Nostrant Breakdown of academic impact, for papers by L. Barbara Breakdown of academic impact, for papers by W. Sircus Breakdown of academic impact, for papers by Paul Kerlin Breakdown of academic impact, for papers by W. O. Kirwan Breakdown of academic impact, for papers by Lawrence DenBesten Breakdown of academic impact, for papers by R. Stockbrügger Breakdown of academic impact, for papers by Bjarni Þjóðleifsson
Rankless by CCL
2026